ERICA KOEHLER-SCHMIDT: Open Payments
NPI 1508590217 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,144 in 127 payments from 20 companies in 2025. Trend: 2023 $1,452 · 2024 $1,585 · 2025 $2,144
Food & beverage: $2,144
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $470 |
| Lundbeck LLC | 23 | $389 |
| Otsuka America Pharmaceutical, Inc. | 14 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $229 |
| Teva Pharmaceuticals USA, Inc. | 13 | $148 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| Alkermes, Inc. | 4 | $73 |
| Biogen, Inc. | 3 | $70 |
| Neos Therapeutics, LP | 4 | $69 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
Products named: REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA, ARISTADA, ZURZUVAE, Sunosi.
Industry payments across NE — which companies pay providers there.
